Backtesting ArenaBacktesting Arena
Backtesting Arena Blog

Arena Blog

Data-driven insights on trading strategies, backtests, and market analysis.

📬 New posts straight to your inbox:

61–72 of 178 posts · page 6 of 15

Strategy

We Rebuilt Our Worst Strategy Correctly — It Worked — and Cut It Anyway

Backtesting Arenatradingstrategies.work

Our Bollinger Squeeze strategy lost to Buy & Hold by double digits on crypto. Before deleting it, we rebuilt it to the modern standard (TTM Squeeze). The rebuild turned positive — and we retired it anyway. Why "it works now" isn't enough.

BacktestingMethodologyMomentum
Jul 1, 20261 min
Strategy

We Fixed Our Fibonacci Strategy — and Retired It Anyway

Backtesting Arenatradingstrategies.work

Auditing 40,000 backtests, our Fibonacci strategy came up short. Before cutting it we asked: is it our config? A better exit made it 20 points better — and we retired it anyway. Why "beats Buy & Hold" isn't the bar.

BacktestingMethodologyBuy & Hold
Jul 1, 20261 min
Tools

40,000 Backtests Later: Which of Our Own Strategies We're Killing

Backtesting Arenatradingstrategies.work

We audited 40,000 of our own backtests — and benched several of our own strategies in the process. Here is what we killed, what we reactivated, and the uncomfortable core lesson: whether a strategy is "good" depends less on the strategy than on the asset class it runs in.

BacktestingBuy & HoldDrawdown+1
Jul 1, 20261 min
Tools

The Agentic Brokerage: Why AI Signals Make Honest Backtesting More Important, Not Less

Backtesting Arenatradingstrategies.work

A thesis says trading platforms are going "agentic" — AI monitors, signals, executes. The structural part is right. The blind spot sits where money is lost.

AI agentsBacktestingRisk management
Jun 30, 20261 min
Market Analysis

Do Credit Flows Lead Crypto? What a Popular Chart Shows — and What It Doesn't

Backtesting Arenatradingstrategies.work

A chart claims to "prove" liquidity leads crypto. The thesis is serious — the chart isn't proof. What it shows, what it doesn't, and how to test it honestly.

CryptoMacroBacktesting
Jun 30, 20261 min
Market Analysis

When the Product Works but the Token Falls: The Zeus Network Case

Backtesting Arenatradingstrategies.work

zBTC runs, it's multi-chain, the product delivers — and the ZEUS token fell about 98%. How does that fit, and what does the road ahead look like? A sober tokenomics case study.

CryptoSolana
Jun 30, 20261 min
Market Structure

Why QT Is Over — and What It Means for US Treasuries

Backtesting Arenatradingstrategies.work

The Fed looks trapped: fight inflation with high rates, or refinance the debt cheaply. But it already resolved part of that bind — by decoupling its tools. A methodical read on what this means for Treasuries.

Macro
Jun 29, 20261 min
Market Analysis

BIP-110 Chain-Split Fears: What's Really at Stake on August 7 — and What Isn't

Backtesting Arenatradingstrategies.work

"Bitcoin splits in August because miners disagree." The date is roughly right, the mechanism in that sentence isn't. What BIP-110 actually triggers — and what it doesn't.

Bitcoin
Jun 29, 20261 min
Market Structure

Is Crypto Safe? Why Crypto Looks Less Secure Than It Is

Backtesting Arenatradingstrategies.work

The "hacked again" reflex is wrong. What the Polymarket case actually shows — and the two places where crypto genuinely is harder.

CryptoDeFi
Jun 28, 20261 min
Backtesting

40,000 Backtests — What the Data Says Now (and What Changed Since 10k)

Backtesting Arenatradingstrategies.work

Five weeks ago it was 10,000 backtests; today it's over 40,000. With 4x the data, the "beats Buy & Hold" rate falls from 64% to 52%, four in five runs land below 50% win rate, and one memecoin still holds its 197,923% record. What selection bias does to sample size — on real numbers.

BacktestingMethodologyBuy & Hold
Jun 24, 20261 min
Market Structure

Option vs. Annuity Machine: Two Ways to Be Invested in the Same AI-Healthcare Sector

Backtesting Arenatradingstrategies.work

"Invested in AI healthcare" can mean two almost opposite things. Two real companies show it: an annuity machine with ~86% recurring revenue — and an option with not a single approved drug. Same label, opposite risk DNA.

AI agentsMethodologyRisk management
Jun 24, 20261 min
Strategy

Why SMC Indicators Look Better Than They Backtest

Backtesting Arenatradingstrategies.work

A smart-money indicator paints clean zones that price seems to respect. Backtest it honestly and the magic fades. The reason is mechanical — repainting and vanished losers — not your skill.

BacktestingMethodology
Jun 23, 20261 min
📬

Don't miss new blog posts

One short email per new post — strategies, backtests, market analysis. No spam, unsubscribe with one click anytime.

By subscribing you accept our privacy policy. We use Resend for delivery. Double opt-in confirmation required.